These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19735093)

  • 81. Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.
    Taymans JM; Cookson MR
    Bioessays; 2010 Mar; 32(3):227-235. PubMed ID: 20127702
    [TBL] [Abstract][Full Text] [Related]  

  • 82. LRRK2 protein is a component of Lewy bodies.
    Zhu X; Siedlak SL; Smith MA; Perry G; Chen SG
    Ann Neurol; 2006 Nov; 60(5):617-618. PubMed ID: 16847950
    [No Abstract]   [Full Text] [Related]  

  • 83. A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.
    Dranka BP; Gifford A; McAllister D; Zielonka J; Joseph J; O'Hara CL; Stucky CL; Kanthasamy AG; Kalyanaraman B
    Neurosci Lett; 2014 Nov; 583():159-64. PubMed ID: 25263790
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 85. G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.
    Gaig C; Martí MJ; Ezquerra M; Cardozo A; Rey MJ; Tolosa E
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686713
    [TBL] [Abstract][Full Text] [Related]  

  • 86. ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.
    Verma M; Steer EK; Chu CT
    Biochim Biophys Acta; 2014 Aug; 1842(8):1273-81. PubMed ID: 24225420
    [TBL] [Abstract][Full Text] [Related]  

  • 87. LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?
    Outeiro TF; Harvey K; Dominguez-Meijide A; Gerhardt E
    Biochem Soc Trans; 2019 Jun; 47(3):827-838. PubMed ID: 31085616
    [TBL] [Abstract][Full Text] [Related]  

  • 88. LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.
    Marcogliese PC; Abuaish S; Kabbach G; Abdel-Messih E; Seang S; Li G; Slack RS; Haque ME; Venderova K; Park DS
    Hum Mol Genet; 2017 Apr; 26(7):1247-1257. PubMed ID: 28158614
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.
    Dranka BP; Gifford A; Ghosh A; Zielonka J; Joseph J; Kanthasamy AG; Kalyanaraman B
    Neurosci Lett; 2013 Aug; 549():57-62. PubMed ID: 23721786
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Lack of central and peripheral nervous system synuclein pathology in R1441G
    Vilas D; Gelpi E; Aldecoa I; Grau O; Rodriguez-Diehl R; Jaumà S; Martí MJ; Tolosa E
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):832-833. PubMed ID: 30054313
    [No Abstract]   [Full Text] [Related]  

  • 91. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.
    Yue Z; Lachenmayer ML
    Mov Disord; 2011 Jul; 26(8):1386-97. PubMed ID: 21538530
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease.
    Rouaud T; Clairembault T; Coron E; Neunlist M; Anheim M; Derkinderen P
    Parkinsonism Relat Disord; 2017 Jul; 40():83-84. PubMed ID: 28483388
    [No Abstract]   [Full Text] [Related]  

  • 93. The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease.
    Cardo LF; Coto E; Ribacoba R; Mata IF; Moris G; Menéndez M; Alvarez V
    J Hum Genet; 2014 Jun; 59(6):346-8. PubMed ID: 24758914
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Benign tremulous parkinsonism in a patient with dardarin mutation.
    Rizzo G; Marconi S; Capellari S; Scaglione C; Martinelli P
    Mov Disord; 2009 Jul; 24(9):1399-401. PubMed ID: 19373934
    [No Abstract]   [Full Text] [Related]  

  • 95. The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress.
    Yakhine-Diop SMS; Rodríguez-Arribas M; Canales-Cortés S; Martínez-Chacón G; Uribe-Carretero E; Blanco-Benítez M; Duque-González G; Paredes-Barquero M; Alegre-Cortés E; Climent V; Aiastui A; López de Munain A; Bravo-San Pedro JM; Niso-Santano M; Fuentes JM; González-Polo RA
    Cell Biol Toxicol; 2022 Oct; 38(5):889-911. PubMed ID: 34060004
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
    Greggio E; Jain S; Kingsbury A; Bandopadhyay R; Lewis P; Kaganovich A; van der Brug MP; Beilina A; Blackinton J; Thomas KJ; Ahmad R; Miller DW; Kesavapany S; Singleton A; Lees A; Harvey RJ; Harvey K; Cookson MR
    Neurobiol Dis; 2006 Aug; 23(2):329-41. PubMed ID: 16750377
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.
    Goldstein DS; Imrich R; Peckham E; Holmes C; Lopez G; Crews C; Hardy J; Singleton A; Hallett M
    Neurology; 2007 Oct; 69(16):1580-4. PubMed ID: 17625107
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
    Paisán-Ruíz C; Jain S; Evans EW; Gilks WP; Simón J; van der Brug M; López de Munain A; Aparicio S; Gil AM; Khan N; Johnson J; Martinez JR; Nicholl D; Martí Carrera I; Pena AS; de Silva R; Lees A; Martí-Massó JF; Pérez-Tur J; Wood NW; Singleton AB
    Neuron; 2004 Nov; 44(4):595-600. PubMed ID: 15541308
    [TBL] [Abstract][Full Text] [Related]  

  • 99. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology.
    Taipa R; Pereira C; Reis I; Alonso I; Bastos-Lima A; Melo-Pires M; Magalhães M
    Brain; 2016 Jun; 139(Pt 6):1680-7. PubMed ID: 27085187
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.
    Bonifati V
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):355-7. PubMed ID: 16928343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.